Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health's lead product, Cala Trio™, is the only non-invasive prescription therapy for essential tremor. New therapies are under development in Parkinson's disease and other indications in neurology, as well as targets in psychiatry, cardiology and autoimmune disorders. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/16/21 | $77,000,000 | Venture |
Ascension Ventures Dolby Family Ventures Innovatus Capital Partners Peak6 Investments | undisclosed |
| 12/09/24 | $50,000,000 | Growth |
Action Potential Venture Capital Ascension Ventures Fiscus Ventures Google Ventures Johnson & Johnson Innovation Lightstone Ventures Lux Capital Nexus NeuroTech Ventures OSF Ventures Peak6 Reimagined Ventures TriVentures Vertex Growth | undisclosed |
